The Texas Medical Center has named its second cohort for its United Kingdom-focused health tech accelerator. Photo via TMC

For the second time, an accelerator backed by the United Kingdom and hosted by Texas Medical Center Innovation has named 16 companies to its new cohort.

In partnership with Innovate UK, TMC named the new cohort companies in an announcement this week. The companies are divided into two categories — digital health and medical device — and cover a wide range of specialties, from diagnostics and AI monitoring to non-surgical management and more.

The accelerator launched last year with its inaugural cohort with the mission of helping companies make their United States expansion by way of the TMC.

"The first cohort of startups in our accelerator program experienced TMC's capabilities in developing and advancing solutions through cross-collaboration with top minds in clinical care, commercialization and innovation," Devin Dunn, head of the Accelerator for Health Tech at TMC, says in a news release. "We are excited to continue our partnership with Innovate UK and welcome this second cohort to continue our efforts advancing life sciences technologies across the globe."

This year's program begins June 4 and will run through November. According to the TMC, last year's cohort had significant success tapping into the health tech ecosystem in Houston, including engaging with investors, setting up a go-to-market strategy, and making inaugural U.S.-based hires.

“Our Global Incubator Programme selects driven and ambitious innovators looking to scale their technologies globally," adds Jon Hazell, partnership manager for the North America and Global Incubator at Innovate UK. "We are excited for our second cohort of startups to join the programme, supported by the Texas Medical Center accelerator, where world-class mentors and programming will help our entrepreneurs understand and meet the requirements of different markets, and build the necessary partnerships, collaborations, and networks, facilitating their entry into global markets."

The selected medical device companies — and their technologies, as described by the TMC — include:

  • Cytecom – infectious diagnostic test, powered by cutting-edge optical electrophysiology, detects resistant bacteria in just 45 seconds, enabling doctors to prescribe targeted antibiotics in minutes instead of days
  • Heartfelt Technologies Ltd – the future of heart failure telemonitoring an automatic, AI supported, non-contact telemonitoring solution for heart failure patients
  • Neurovalens Ltd – creates wearable neurostimulaton devices that treat a range of conditions in an entirely non-invasive and drug-free way
  • Oxford Medical Products Limited – a proprietary hydrogel pill that acts as a non-surgical, non-pharmacological obesity treatment that will redefine the obesity treatment market
  • Phenutest – a rapid point-of-care diagnostic test for urinary tract infection, that confirms infection and appropriate antimicrobial to prescribe within 60 minutes
  • Plexaa – world's first fully wearable, sensor controlled, bra insert that can deliver safe supraphysiological preconditioning to the breast skin the night before surgery at home
  • SolasCure Limited – a wound Gel that acts as a single, effective and easy-to-use solution to overcome the challenges to transform chronic wound care
  • Trueinvivo Limited – a proprietary dosimetry (radiation measurement) system to ensure the precision and accuracy of cancer radiotherapy

The selected digital health companies — and their technologies, as described by the TMC — include:

  • Axon Diagnostics – offers a suite of solutions to support the needs of modern day diagnostic imaging services, supporting happier lives for clinicians and helping deliver better diagnostic care for all
  • Kheiron Medical Technologies – regarded as a world leader in the development of AI-enabled cancer diagnostics and monitoring
  • KiActiv – a technology-enabled digital health model for behaviour change and self-care that rethinks exercise and makes everyday movement an effective personalized medicine for better clinical outcomes
  • Memory Lane Games – turns memories into games, offering care providers a simple, fun dementia engagement app designed to trigger positive memories and improve socialisation with caregivers and people living with dementia
  • NeuroVirt Limited – combines immersive VR, AI and computer vision to gamify rehabilitation and quantify patient impairment and improvement
  • Newton’s Tree – enables healthcare providers to procure, integrate, and monitor third party AI products as part of routine care pathways through its enterprise AI platform
  • SERG Technologies – uses patented sensor technology and artificial intelligence to transform disease management into a continuous, data driven, and patient specific approach for people with Parkinson’s
  • Thymia – leverages speech, video, and behavioral analytics gathered via specially designed video games to diagnose conditions like depression, anxiety, and ADHD, alongside critical symptoms like fatigue, mood fluctuations, and memory issues, creating novel mental health biomarkers
The partnership between the U.K. and TMC began in 2018 as a biobridge between the two entities. TMC has expanded into new biobridges with other countries — most recently with The Netherlands — and also has a Danish accelerator that's also running its second cohort this summer.
The Texas Medical Center Innovation Factory has named the 16 companies making up the inaugural cohort in the Innovate UK Global Incubator Programme. Photo via tmc.edu

TMC names inaugural cohort for unique accelerator with UK

coming to HOU

Sixteen digital health and medical device startups founded in the United Kingdom have been selected for a customized accelerator at the Texas Medical Center's Innovation Factory.

In partnership with Innovate UK, TMCi created the Innovate UK Global Incubator Programme, a new accelerator that supports UK businesses as they build their United States go-to-market plan. The program builds the BioBridge relationship between TMC and the UK that was originally established five years ago.

“The TMC UK BioBridge program was launched with the UK Department for Business and Trade in 2018 to serve as a gateway for advancing life sciences and foster innovation and research between our two countries," says Ashley McPhail, chief external affairs and administration officer for TMC, in a news release. "We saw an opportunity to work with Innovate UK to develop a larger program with the UK after the success of the 11 companies that previously participated in our health tech accelerator."

The 16 companies will participate in the program from June to November. The cohort is expected to arrive in Houston on June 5 and have access to TMCi's facilities, network of mentors and potential clients, funding, potential customers, and curated programing — all while being a unique entry point into the US. The new offering joins three other globally recognized curriculums: Biodesign, Accelerator for Cancer Therapeutics, and Health Tech.

“TMCi nurtures long-term growth, development, and competitiveness to increase startups chances of success and global expansion," says Emily Reiser, associate director of TMC Innovation. "By bringing their novel technologies and exposing them to a curated selection of TMC’s expert network, startups receive support and evaluation to build, scale, and expand in the US market."

Two of the cohort's specialties include cardiovascular and oncology — two of TMC's strongest areas of expertise — with solutions ranging from surgical devices to AI-enabled risk stratification and hospital efficiency.

Innovate UK is the country's national innovation agency dedicated to supporting business-led innovation in all sectors.

“The United Kingdom is fully committed to improving global healthcare through scientific collaboration," says His Majesty’s Consul General in Texas Richard Hyde in the release. "Through the expansion of the TMC UK BioBridge and in partnership with Innovate UK, this programme will help to expose the brightest and best British companies to the world’s largest medical city. Our companies will collaborate and grow as they work to develop cutting edge technology. The partnership between the UK Government and TMC demonstrates that international collaboration can drive both economic growth and improvement to quality of life.”

The 16 companies making up the inaugural cohort are as follows, according to TMC.

  • AINOSTICS aims to revolutionize the treatment and prevention of neurological conditions, such as dementia, by developing innovative AI-enabled solutions that draw novel insights from routinely acquired non-invasive medical scans to deliver accurate diagnosis and outcome prediction, and in turn facilitate personalized care and timely access to disease-modifying treatments for patients.
  • Alvie is a blended human plus AI-enabled digital solution providing personalised pre and rehabilitation coaching and supportive care for cancer and surgery. Alvie's technology combines data profiling, risk-stratification and tailored prescriptions of health and well-being with curated educational content, targeted behaviour change coaching and expert support through chat messaging and virtual consultations.
  • C the Signs™ is a validated AI cancer prediction platform, which can identify patients at risk of cancer at the earliest and most curable stage of the disease. Used by healthcare professionals, C the Signs can identify which tumor type a patient is at risk of and recommend the most appropriate next step in less than 30 seconds. The platform has detected over 10,000 patients with cancer, with over 50 different types of cancer diagnosed, and with a sensitivity of >98% for cancer.
  • At PEP Health, We believe all patients deserve the best care possible. Our cutting-edge machine-learning technology enables healthcare organisations, regulators, and insurers the real-time, actionable insights they need to have a direct and dramatic impact on patient experiences.
  • PreciousMD improves the lives of lung-cancer and other lung-related illnesses patients worldwide by enabling imaging-based diagnostics needed for personalized treatment pathways.
  • Ufonia is an autonomous telemedicine company, we use large language models and voice AI to increase the capacity of clinical professionals.
  • My mhealth offers digital therapeutics for a range of long-term conditions- COPD, Asthma, Diabetes and Heart Disease. Our product has been successfully deployed in the UK and India, with >100,000 users registered to date. Our solutions empower patients to self-manage their conditions, resulting in dramatic improvements in outcomes, as evidenced through multiple clinical trials and real-world evaluations.
  • At Surgery Hero, we offer a clinically backed solution that ensures whole-human support before and after surgery. We help health systems, employers and health plans cut costs without sacrificing quality of care.
  • Panakeia's software platform enables extremely rapid multi-omics profiling in minutes directly from routinely used tissue images without needing wet lab assays.
  • QV Bioelectronics are striving to deliver longer, better quality lives for brain tumour patients. Using their first-of-its-kind implantable electric field therapy device, GRACE, QV will provide effective, focal & continuous treatment without impacting patient quality of life.
  • 52 North is a med-tech company focused on improving health outcomes and health equity by reinventing care pathways. The NeutroCheck® solution is a finger-prick blood test and digital platform built to significantly improve safety and quality of life for cancer patients, by helping to identify at-home those patients who are at risk of the most fatal side-effect of chemotherapy: neutropenic sepsis.
  • Somnus is fulfilling an unmet need in global healthcare by developing real-time, point of care blood propofol monitoring. Its products will improve the care of sedated and anaesthetised patients, save money for hospitals, and facilitate a major reduction in greenhouse gas emissions.
  • ScubaTx is a breakthrough organ transplant preservation company established to solve the global unmet need for cost-efficient and longer-duration organ preservation technology. ScubaTx has developed a simple, small and affordable device which uses Persufflation to extend the preservation of organs.
  • IBEX is on a mission to help people live active, healthy and productive lives by increasing their access to early diagnosis of osteoporosis. The IBEX BH software as medical device delvers routine, automated assessment of fracture risk from routine radiology for earlier detection and more equitable treatment of osteoporosis.
  • NuVision produces products derived from donated human amniotic membrane that are used in ophthalmology to help patients with chronic, traumatic and post-surgical wounds of the eye to be treated earlier and recover more fully and more quickly. The company’s products are also used in the management of dry eye disease, a debilitating conditions that affects around 17m people in the USA.
  • Calon Cardio-Technology is on a mission to improve quality of life for patients with Left Ventricular Assist devices (LVAD) and reduce the common post operative complications associated with these implantable heart pumps. We plan to do this by introducing a completely wireless heart pump system and augment patient follow-up with built-in remote monitoring capabilities.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Rice University inks strategic partnership with French research institution

collaboration station

Rice University and Université Paris Sciences & Lettres signed a strategic partnership agreement last week that states that the two institutions will work together on research on some of today's most pressing subject matters.

According to an announcement made on May 13 in Paris, the two schools and research hubs will collaborate on work focused on "fields of energy and climate; quantum computing and artificial intelligence; global health and medicine; and urban futures."

The partnership allows Rice to expand its presence in France, after launching its Rice Global Paris Center about two years ago.

Université PSL consists of 11 top research institutes in France and 2,900 world-class researchers and 140 research laboratories.

“We are honored and excited to partner with Paris Sciences and Lettres University and join forces to advance bold innovation and find solutions to the biggest global challenges of our time,” Rice President Reginald DesRoches said in a statement. “The unique strengths and ambitions of our faculty, students, scholarship and research are what brings us together, and our passion and hope to build a better future for all is what will drive our partnership agenda. Representing two distinct geographic, economic and cultural regions known for ingenuity and excellence, Rice and PSL’s efforts will know no bounds.”

Rice and Université PSL plan to host conferences around the four research priorities of the partnership. The first took place last week at the Rice Global Paris Center. The universities will also biannually select joint research projects to support financially.

“This is a global and cross-disciplinary partnership that will benefit from both a bottom-up, research-driven dynamic and a top-down commitment at the highest level,” PSL President Alain Fuchs said in a statement. “The quality and complementarity of the researchers from PSL and Rice who mobilized for this event give us reason to believe that this partnership will get off to a rapid and productive start. It will offer a strong framework to all the PSL schools for developing collaborations within their areas of strength and their natural partners at Rice.”

Rice launched its Rice Global Paris Center in June 2022 in a historic 16th-century building in Le Marais. At the time it, the university shared that it was intended to support Rice-organized student programs, independent researchers, and international conferences, as well as a satellite and hub for other European research activity.

"Rice University's new home in the Marais has gone from an idea to a mature relative with a robust program of faculty research summits, student opportunities, cultural events and community engagement activities," Caroline Levander, Rice's global Vice President, said at the announcement of the partnership last week.

Click here to learn more about the Global Paris Center.

Last month, University of Houston also signed a memorandum of understanding with Heriot-Watt University in Scotland to focus on hydrogen energy solutions.

------

This article originally ran on EnergyCapital.

Houston jumps significantly on annual list of best places to live in 2024

by the numbers

Things are looking a little brighter for Houston as the city was recently named among the top 100 best places to live in U.S. News and World Report's "Best Places to Live" list for 2024-2025.

Previously, H-Town had shockingly plummeted toward the bottom of the list as No. 140 in the 2023-2024 rankings. But the latest report has placed Houston at No. 97, suggesting substantial improvements over the last year.

U.S. News annually measures 150 top American cities for their livability and ranks them based on four major indexes: quality of life, value, desirability, and job market.

New for the 2024-2025 report, U.S. News updated its methodology to analyze city-based data rather than metropolitan area data. Secondly, the report's annual survey decided to place greater weight on a city's "value and job market" while "weights for desirability and quality of life took a slight dip" on the grading scale.

"Rising concerns about career prospects, housing affordability and increased cost of goods and services are reflected in this year’s rankings," said U.S. News loans expert and reporter Erika Giovanetti in a press release. "While quality of life remains the top priority for many Americans, a city’s value and job market are becoming increasingly important for those looking for a place to live."

There's many factors that draw folks to Houston, among them our city's diversity, the highly esteemed schools, top universities, and much more. Houston is also a great place for retirees looking to settle down without compromising on the big city lifestyle. The city truly has something for everyone.

The good news continues: Houston additionally moved up two spots to take No. 8 on the report's Best Place to Live in Texas list for 2024. The Bayou City ranked No. 10 last year.

Elsewhere in Texas
The recent focus on city-based data was likely a major factor that fueled Houston's improvement in the statewide and national rankings, but it also favorably shifted nine other Texas cities.

Austin – which previously ranked No. 40 in last year's rankings – became the only city to represent the Lone Star State among the top 10 best places to live in 2024. The Texas Capital jumped up 31 spots to claim No. 9 nationally, due to its "high desirability and job market scores," the report said.

Three cities in the Rio Grande Valley also ranked higher than Houston, suggesting that South Texas may be a better place to live than East Texas. The border towns of McAllen (No. 48) and Brownsville (No. 87) climbed into the overall top 100 this year after formerly ranking No. 137 and No. 134 last year. Meanwhile, Corpus Christi moved up from No. 132 last year to No. 77 in 2024.

Naples, Florida won the gold medal as the No. 1 best place to live in the U.S. in 2024. Rounding out the top five are Boise, Idaho (No. 2); Colorado Springs, Colorado (No. 3); Greenville, South Carolina (No. 4); and Charlotte, North Carolina (No. 5).

Here's how other Texas cities faired in 2024's Best Places to Live report:

  • No. 62 – El Paso (up from No. 128 last year)
  • No. 89 – San Antonio (up from No. 103 last year)
  • No. 95 – Dallas (up from No. 113 last year)
  • No. 99 – Beaumont (up from No. 131 last year)
  • No. 107 – Killeen (up from No. 122 last year)
The full report and its methodology can be found on realestate.usnews.com.

------

This article originally ran on CultureMap.

Houston organizations launch study to explore hydrogen-powered travel

sustainability takes flight

A few major players have teamed up to look into making air travel more sustainable — and it's all happening in Houston.

The Center for Houston’s Future, Airbus, and Houston Airports have signed a memorandum of understanding intended to study the “feasibility of a hydrogen hub at George Bush Intercontinental Airport." The study, which will conclude in March of 2025, will include the participants that will collaborate ways to rethink how their infrastructures could be designed and operated to reduce an overall environmental footprint, and lead to hydrogen-powered aircrafts like the ones Airbus plans to bring to fruition by 2035.

In 2020, Airbus debuted its ZEROe hydrogen-powered aircraft project. The “Hydrogen Hub at Airports'' concept by Airbus unites key airport ecosystem players to develop ways to decarbonize all airport-associated infrastructure with hydrogen. The study will include airport ground transportation, airport heating, end-use in aviation, and possibly ways to supply adjacent customers in transport and local industries.

The use of hydrogen to power future aircraft aims to assist in eliminating aircraft CO2 emissions in the air, and also can help decarbonize air transport on the ground. With Houston being such a large city, and a destination for some many visiting on business, the Houston airports was an easy spot to assign the study.

"Houston’s airports are experiencing tremendous growth, connecting our city to the world like never before,” Jim Szczesniak, the aviation director for the city of Houston, says in a news release. “As we continue to expand and modernize our facilities, participating in this sustainability study is crucial. Continuing to build a sustainable airport system will ensure a healthy future for Houston, attract top talent and businesses, and demonstrate our commitment to being a responsible global citizen.

"This study will provide us with valuable insights to guide our development and position Houston as a global leader in sustainable aviation innovation for generations to come.”

The CHF was a founding organizer of the HyVelocity Hydrogen Hub, which was selected by the U.S. Department of Energy as one of seven hydrogen hubs in the nation, and will work in the Houston area and the Gulf Coast. The HyVelocity Hydrogen Hub is eligible to receive up to $1.2 billion as part of a Bipartisan Infrastructure Law funding to advance domestic hydrogen production.

“The Center for Houston’s Future is pleased to have played a crucial role in bringing together the partners for this study,” Brett Perlman, the center's outgoing CEO and president, adds. “With Houston’s role as the world’s energy capital, our record of energy innovation and desire to lead in the business of low-carbon energy, Houston is the perfect place to develop our airports as North American clean hydrogen pioneers.”